Literature DB >> 30535712

The hemoglobin adduct N-(2,3-dihydroxypropyl)-valine as biomarker of dietary exposure to glycidyl esters: a controlled exposure study in humans.

Klaus Abraham1, Jan Hielscher2, Tobias Kaufholz3, Hans Mielke3, Alfonso Lampen2, Bernhard Monien2.   

Abstract

Fatty acid esters of glycidol (glycidyl esters) are heat-induced food contaminants predominantly formed during industrial deodorization of vegetable oils and fats. After consumption, the esters are digested in the gastrointestinal tract, leading to a systemic exposure to the reactive epoxide glycidol. The compound is carcinogenic, genotoxic and teratogenic in rodents, and rated as probably carcinogenic to humans (IARC group 2A). Assessment of exposure from occurrence and consumption data is difficult, as lots of different foods containing refined oils and fats may contribute to human exposure. Therefore, assessment of the internal exposure using the hemoglobin adduct of glycidol, N-(2,3-dihydroxypropyl)-valine (2,3-diHOPr-Val), may be promising, but a proof-of-principle study is needed to interpret adduct levels with respect to the underlying external exposure. A controlled exposure study was conducted with 11 healthy participants consuming a daily portion of about 36 g commercially available palm fat with a relatively high content of ester-bound glycidol (8.7 mg glycidol/kg) over 4 weeks (total amount 1 kg fat, individual doses between 2.7 and 5.2 µg/kg body weight per day). Frequent blood sampling was performed to monitor the 2,3-diHOPr-Val adduct levels during formation and the following removal over 15 weeks, using a modified Edman degradation and ultrahigh performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS). Results demonstrated for the first time that the relatively high exposure during the intervention period was reflected in corresponding distinct increases of 2,3-diHOPr-Val levels in all participants, following the expected slope for hemoglobin adduct formation and removal over time. The mean adduct level increased from 4.0 to 12.2 pmol 2,3-diHOPr-Val/g hemoglobin. By using a nonlinear mixed model, values for the adduct level/dose ratio (k, mean 0.082 pmol 2,3-diHOPr-Val/g hemoglobin per µg glycidol/kg body weight) and the adduct lifetime (τ, mean 104 days, likely the lifetime of the erythrocytes) were determined. Interindividual variability was generally low. 2,3-DiHOPr-Val was therefore proven to be a biomarker of the external dietary exposure to fatty acid esters of glycidol. From the background adduct levels observed in our study, a mean external glycidol exposure of 0.94 µg/kg body weight was estimated. This value is considerably higher than current estimates for adults using occurrence and consumption data of food. Possible reasons for this discrepancy are discussed (other oral or inhalational glycidol sources, endogenous formation, exposure to other chemicals also forming the adduct 2,3-diHOPr-Val). Further research is necessary to clarify the issue.

Entities:  

Keywords:  Biomarker; Edman degradation; Exposure study; Glycidol; Protein adduct

Mesh:

Substances:

Year:  2018        PMID: 30535712     DOI: 10.1007/s00204-018-2373-y

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  8 in total

Review 1.  Mode of action-based risk assessment of genotoxic carcinogens.

Authors:  Andrea Hartwig; Michael Arand; Bernd Epe; Sabine Guth; Gunnar Jahnke; Alfonso Lampen; Hans-Jörg Martus; Bernhard Monien; Ivonne M C M Rietjens; Simone Schmitz-Spanke; Gerlinde Schriever-Schwemmer; Pablo Steinberg; Gerhard Eisenbrand
Journal:  Arch Toxicol       Date:  2020-06-15       Impact factor: 5.153

2.  Nutritional Intake and Biomarker Status in Strict Raw Food Eaters.

Authors:  Klaus Abraham; Iris Trefflich; Fabian Gauch; Cornelia Weikert
Journal:  Nutrients       Date:  2022-04-21       Impact factor: 6.706

Review 3.  The role of endogenous versus exogenous sources in the exposome of putative genotoxins and consequences for risk assessment.

Authors:  Ivonne M C M Rietjens; Arand Michael; Hermann M Bolt; Bourdoux Siméon; Hartwig Andrea; Hinrichsen Nils; Kalisch Christine; Mally Angela; Pellegrino Gloria; Ribera Daniel; Thatcher Natalie; Eisenbrand Gerhard
Journal:  Arch Toxicol       Date:  2022-03-06       Impact factor: 6.168

4.  Internal Doses of Glycidol in Children and Estimation of Associated Cancer Risk.

Authors:  Jenny Aasa; Efstathios Vryonidis; Lilianne Abramsson-Zetterberg; Margareta Törnqvist
Journal:  Toxics       Date:  2019-02-01

5.  Does External Exposure of Glycidol-Related Chemicals Influence the Forming of the Hemoglobin Adduct, N-(2,3-dihydroxypropyl)valine, as a Biomarker of Internal Exposure to Glycidol?

Authors:  Yuko Shimamura; Ryo Inagaki; Hiroshi Honda; Shuichi Masuda
Journal:  Toxics       Date:  2020-12-13

Review 6.  Quo vadis blood protein adductomics?

Authors:  Gabriele Sabbioni; Billy W Day
Journal:  Arch Toxicol       Date:  2021-11-13       Impact factor: 5.153

7.  Simultaneous quantification of eight hemoglobin adducts of genotoxic substances by isotope-dilution UHPLC-MS/MS.

Authors:  Fabian Gauch; Klaus Abraham; Bernhard H Monien
Journal:  Anal Bioanal Chem       Date:  2022-06-02       Impact factor: 4.478

8.  Assessment of the potential vaping-related exposure to carbonyls and epoxides using stable isotope-labeled precursors in the e-liquid.

Authors:  Anne Landmesser; Max Scherer; Gerhard Scherer; Mohamadi Sarkar; Jeffery S Edmiston; Reinhard Niessner; Nikola Pluym
Journal:  Arch Toxicol       Date:  2021-06-22       Impact factor: 5.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.